Disease Model Mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Product No	Product	Application area
110172	B-ob/ob mice	hyperglycemia and obesity
110170	B-F9 KO mice	hemophilia B
110169	B-F8 KO mice	VII-related coagulopathy disorders
110168	B-Apoe KO mice	cardiovascular disease, lipid metabolism, and Alzheimer’s diseases
110167	B-p53 KO mice	regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism
210509	B-Pink1 KO rats	mitochondrial signaling and Parkinson’s disease
210508	B-Apoe KO rats	diabetes and obesity research, cardiovascular research, atherosclerosis, metabolism research and Alzheimer’s diseases
210506	B-Ldlr KO rats	diabetes and obesity research, cardiovascular research, metabolism research
210505	B-Apoa4 KO rats	regulating appetite and satiety
210507	B-p53 KO rats	cell cycle arrest, apoptosis, senescence, DNA repair and metabolism
112250	B-Rag2/F8 DKO mice	0
112455	B-Il36a/Il36b/Il36g KO mice	0
210510	B-PrP-hAPP-hPS1 rats	0
110875	B-Trp53 mKI(p.Arg172His) mice	0
111259	B-Adipor1 KO mice	0
112567	B-Grn KO mice	0
112357	ROSA26 5xFAD KI mice	0
112036	B-MUP-uPA mice	0
111127	B-Igh-J KO mice(C)	Tumor

Biocytogen is headquartered in Beijing, with branches in Haimen, Jiangsu, Boston, Shanghai. Its wholly-owned subsidiary, Eucure Biopharma, focuses on clinical development.